O'Shaughnessy Asset Management’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$669K Buy
24,346
+8,263
+51% +$220K ﹤0.01% 1462
2026
Q1
$432K Buy
16,083
+961
+6% +$28.8K ﹤0.01% 1602
2025
Q4
$466K Buy
15,122
+5,977
+65% +$186K ﹤0.01% 1538
2025
Q3
$280K Buy
+9,145
New +$223K ﹤0.01% 1786
2024
Q4
Sell
-17,503
Closed -$414K 2235
2024
Q3
$414K Buy
+17,503
New +$468K ﹤0.01% 1315
2024
Q2
Sell
-8,511
Closed -$255K 1992
2024
Q1
$255K Buy
+8,511
New +$250K ﹤0.01% 1396
2023
Q4
Sell
-5,826
Closed -$205K 1757
2023
Q3
$205K Buy
+5,826
New +$222K ﹤0.01% 1275
2023
Q1
Sell
-5,028
Closed -$213K 1511
2022
Q4
$213K Buy
+5,028
New +$207K ﹤0.01% 1094
2021
Q4
Sell
-2,692
Closed -$118K 1722
2021
Q3
$118K Buy
2,692
+50
+2% +$2.25K ﹤0.01% 1303
2021
Q2
$108K Buy
2,642
+163
+7% +$6.29K ﹤0.01% 1274
2021
Q1
$81K Buy
2,479
+155
+7% +$5.83K ﹤0.01% 1277
2020
Q4
$94K Buy
2,324
+89
+4% +$3.33K ﹤0.01% 1089
2020
Q3
$82K Buy
2,235
+410
+22% +$14.8K ﹤0.01% 956
2020
Q2
$62K Buy
1,825
+1,261
+224% +$34.4K ﹤0.01% 960
2020
Q1
$12K Sell
564
-287
-34% -$6.4K ﹤0.01% 999
2019
Q4
$19K Buy
+851
New +$18.6K ﹤0.01% 1157

Other funds holding GMAB

O'Shaughnessy Asset Management's GMAB Position: Q2 2026 in Review

O'Shaughnessy Asset Management increased its Genmab (GMAB) stake by 51% in Q2 2026, buying an estimated $220K and bringing the position to 24,346 shares worth $669K. The position accounts for ﹤0.01% of the portfolio, ranked #1462.

O'Shaughnessy Asset Management first reported a position in GMAB in Q4 2019 and has held it in 16 quarters since. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • O'Shaughnessy Asset Management held 24,346 shares of Genmab worth $669K as of Q2 2026.
  • O'Shaughnessy Asset Management bought 8,263 Genmab shares in Q2 2026, an estimated $220K.
  • Genmab made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1462 holding.
  • O'Shaughnessy Asset Management first reported a position in Genmab in Q4 2019 and has held it in 16 quarters since.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.